Hertel Exophthalmometry Values in Mexican Adults (HERTEL-MX)

Hertel Exophthalmometry Values in Mexican Adults and Their Association With Demographic Factors and Systemic Diseases

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics (such as age and sex) and systemic diseases. Healthy adult participants and adults with selected systemic conditions will undergo standardized Hertel exophthalmometry measurements. The findings are expected to provide population-specific reference values that may improve the clinical assessment of orbital diseases in the Mexican population.

Study Overview

Detailed Description

Background: Hertel exophthalmometry is the most commonly used method for measuring globe protrusion in clinical practice. Normal exophthalmometric values vary according to ethnicity, sex, age, and craniofacial anatomy; therefore, population-specific reference values are necessary for accurate clinical interpretation. Currently, normative data for Mexican adults are limited.

Objective: To establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics and systemic diseases.

Methods: This is a prospective observational study. Adult participants attending the Ophthalmology Department will be consecutively recruited after providing written informed consent. Hertel exophthalmometry measurements will be obtained using a standardized technique by trained examiners. Demographic information, including age and sex, as well as relevant medical history and systemic diseases, will be recorded. The primary outcome is the distribution of Hertel exophthalmometry values in the study population. Secondary analyses will assess associations between exophthalmometric measurements and demographic or systemic variables.

Expected Significance: The study will provide normative Hertel exophthalmometry values for the Mexican adult population and identify factors associated with physiological variations in globe protrusion. These findings may improve the clinical evaluation of patients with suspected orbital disease and facilitate interpretation of Hertel exophthalmometry measurements in routine ophthalmic practice.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Mexico City
      • Mexico City, Mexico City, Mexico, 94806
        • Recruiting
        • ✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult Mexican participants (≥18 years) recruited from the Ophthalmology Department who meet the eligibility criteria. Participants with and without systemic diseases will be included to establish normative Hertel exophthalmometry values and evaluate their association with demographic characteristics and systemic conditions.

Description

Inclusion Criteria:

  • Adults aged 18 years or older.
  • Mexican participants or individuals who self-identify as Mexican.
  • Ability to understand the study procedures and provide written informed consent.
  • Ability to undergo bilateral Hertel exophthalmometry.
  • Participants with or without previously diagnosed systemic diseases.

Exclusion Criteria:

  • Active thyroid eye disease
  • History of orbital trauma or orbital fracture.
  • Previous orbital surgery, orbital decompression, or surgery that may alter globe position.
  • Presence or history of an orbital tumor, orbital inflammation, or orbital infection.
  • Craniofacial abnormalities or facial asymmetry that may interfere with Hertel exophthalmometry.
  • Ocular or eyelid conditions that prevent accurate positioning or measurement with the Hertel exophthalmometer.
  • Inability to cooperate with the examination or obtain a reliable exophthalmometry measurement.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Mexican Adult Participants
Adult Mexican participants undergoing standardized Hertel exophthalmometry and collection of demographic and medical history information for the establishment of normative exophthalmometric values and evaluation of associated factors.
Standardized bilateral Hertel exophthalmometry performed using a Hertel exophthalmometer to measure globe protrusion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hertel Exophthalmometry Value
Time Frame: At baseline
Bilateral Hertel exophthalmometry measurements (millimeters) obtained using a standardized Hertel exophthalmometer. Normative values will be estimated and summarized for the study population.
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2026

Primary Completion (Estimated)

December 28, 2026

Study Completion (Estimated)

December 28, 2026

Study Registration Dates

First Submitted

July 10, 2026

First Submitted That Met QC Criteria

July 10, 2026

First Posted (Actual)

July 15, 2026

Study Record Updates

Last Update Posted (Actual)

July 15, 2026

Last Update Submitted That Met QC Criteria

July 10, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HERTEL-MX-2026-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

3
Subscribe